PREFER - Why, when and how to assess and use patient preferences in medical product decision-making
Published November 25, 2021 | Version v1
Other Open

Processes, conditions and contextual factors that influence the utility and role of patient preference studies

Creators

  • 1. University of Leuven
  • 2. Erasmus University of Rotterdam
  • 3. Johnson & Johnson
  • 4. CSL Behring

Description

The aim of this study was to identify conditions and contextual factors that have a broad and meaningful influence on the utility and role of patient preference studies. Additionally, it was sought to identify existing processes integrating patient preferences in decision making throughout the development, approval and post-approval stages of medical products.

Files

115966_PREFER_Deliverable_2.2_final_2.pdf

Files (3.3 MB)

Name Size Download all
md5:ed0be2d719c9f0a1152fddf226061ede
3.3 MB Preview Download

Additional details

Funding

European Commission
PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966